We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCBC
3501
DELISTED
Macatawa Bank Corp
MCBC
$113K ﹤0.01%
11,722
-15,075
-56% -$157K
RENO
3502
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$113K ﹤0.01%
69,535
-19,091
-22% -$52.1K
NOA
3503
North American Construction
NOA
$361M
$111K ﹤0.01%
+12,424
New +$122K
PR
3504
Permian Resources
PR
$19.8B
$111K ﹤0.01%
10,104
-4,126,512
-100% -$70.8M
WNEB icon
3505
Western New England Bancorp
WNEB
$278M
$110K ﹤0.01%
10,974
-7,551
-41% -$74.9K
TTPH
3506
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$110K ﹤0.01%
4,848
-22,543
-82% -$882K
CVEO icon
3507
Civeo
CVEO
$348M
$109K ﹤0.01%
+6,330
New +$187K
MACK
3508
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$109K ﹤0.01%
35,822
-134,047
-79% -$465K
TRVN
3509
DELISTED
Trevena, Inc.
TRVN
$108K ﹤0.01%
404
-638
-61% -$360K
NEW
3510
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$107K ﹤0.01%
1,817
-4,855
-73% -$340K
VTA
3511
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$107K ﹤0.01%
10,373
-3,092
-23% -$33.8K
ABDC
3512
DELISTED
Alcentra Capital Corp
ABDC
$107K ﹤0.01%
+16,469
New +$103K
IMDZ
3513
DELISTED
Immune Design Corp.
IMDZ
$105K ﹤0.01%
80,794
+70,193
+662% +$122K
IRIX icon
3514
IRIDEX
IRIX
$13M
$103K ﹤0.01%
21,928
-32,534
-60% -$162K
AVID
3515
DELISTED
Avid Technology Inc
AVID
$103K ﹤0.01%
21,663
-41,035
-65% -$237K
HYAC
3516
DELISTED
Haymaker Acquisition Corp. Class A Common Stock
HYAC
$102K ﹤0.01%
+10,182
New +$102K
PBT
3517
Permian Basin Royalty Trust
PBT
$1.62B
$100K ﹤0.01%
+16,933
New +$119K
AEG icon
3518
Aegon
AEG
$13.6B
$99K ﹤0.01%
24,849
-94,053
-79% -$459K
VATE icon
3519
INNOVATE Corp
VATE
$102M
$97K ﹤0.01%
3,692
-4,597
-55% -$194K
NVLN
3520
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$97K ﹤0.01%
113,217
-118,338
-51% -$134K
TGA
3521
DELISTED
Transglobe Energy Corp
TGA
$96K ﹤0.01%
51,299
-181,986
-78% -$428K
CHY
3522
Calamos Convertible and High Income Fund
CHY
$1.04B
$95K ﹤0.01%
+10,100
New +$108K
NATR icon
3523
Nature's Sunshine
NATR
$252M
$95K ﹤0.01%
11,701
-19,863
-63% -$172K
WPG
3524
DELISTED
Washington Prime Group Inc.
WPG
$95K ﹤0.01%
2,166
-5,260
-71% -$295K
NES
3525
DELISTED
Nuverra Environmental Solutions, Inc. Common Stock
NES
$95K ﹤0.01%
11,564
-14,073
-55% -$138K

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.